BRD2 and HIV infectious disease: The use of pooled NAT has detected between 3.9% and 10.5% additional HIV infections when compared with second- or third-generation antibody screening tests in sexually transmitted infection clinics and sites patronized by men who have sex with men (MSM) [11,16].